title: [Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide].
authors.forename: T
authors.initials: T
authors.lastname: Robak
authors.forename: E
authors.initials: E
authors.lastname: Krykowski
authors.forename: W
authors.initials: W
authors.lastname: Matusewicz
authors.forename: L
authors.initials: L
authors.lastname: Brodowski
authors.forename: A
authors.initials: A
authors.lastname: Hołub
authors.forename: J
authors.initials: J
authors.lastname: Drzewoski
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage*; D004351:Drug Resistance; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
chemical_list: D003561:Cytarabine; D005047:Etoposide
vernacular_title: Wyniki leczenia ostrej białaczki szpikowej opornej na konwencjonalna chemioterapie za pomoca średnio duzych dawek cytarabiny i etopozydu.